Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Deurzen, C.H. van"'
Autor:
Marchi, T. De, Timmermans, A.M., Smid, M., Look, M.P., Stingl, C., Opdam, M., Linn, S.C., Sweep, C.G.J., Span, P.N., Kliffen, M., Deurzen, C.H. van, Luider, T.M., Foekens, J.A., Martens, J.W., Umar, A., Albers, E.M.
Publikováno v:
ResearcherID
Oncotarget, 7, 3, pp. 3098-3110
Oncotarget
Oncotarget, 7, 3098-3110
Oncotarget, 7(3), 3098. Impact Journals
Oncotarget, 7, 3, pp. 3098-3110
Oncotarget
Oncotarget, 7, 3098-3110
Oncotarget, 7(3), 3098. Impact Journals
Tamoxifen therapy resistance constitutes a major cause of death in patients with recurrent estrogen receptor (ER) positive breast cancer. Through high resolution mass spectrometry (MS), we previously generated a 4-protein predictive signature for tam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a306cdaca012f11211373754d3cfc8c9
https://doi.org/10.18632/oncotarget.6521
https://doi.org/10.18632/oncotarget.6521
Autor:
Deurzen, C.H. van, Boer, M. de, Bult, P., Dijck, J.A.A.M. van, Tjan-Heijnen, V.C., Diest, P.J. van
Publikováno v:
Nederlands Tijdschrift voor Oncologie, 7, 21-28
Nederlands Tijdschrift voor Oncologie, 7, 1, pp. 21-28
Nederlands Tijdschrift voor Oncologie, 7, 1, pp. 21-28
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0f26f519ba143ef038badc9907810c86
https://hdl.handle.net/2066/88637
https://hdl.handle.net/2066/88637
Autor:
Sobral-Leite, M., Wesseling, J., Smit, V.T., Nevanlinna, H., Miltenburg, M.H. van, Sanders, J., Hofland, I., Blows, F.M., Coulson, P., Patrycja, G., Schellens, J.H., Fagerholm, R., Heikkilä, P., Aittomäki, K., Blomqvist, C., Provenzano, E., Ali, H.R., Figueroa, J., Sherman, M., Lissowska, J., Mannermaa, A., Kataja, V., Kosma, V.M., Hartikainen, J.M., Phillips, K.A., Couch, F.J., Olson, J.E., Vachon, C., Visscher, D., Brenner, H., Butterbach, K., Arndt, V., Holleczek, B., Hooning, M.J., Hollestelle, A., Martens, J.W., Deurzen, C.H. van, Water, B. van de, Broeks, A., Chang-Claude, J., Chenevix-Trench, G., Easton, D.F., Pharoah, P.D., García-Closas, M., Graauw, M. de, Schmidt, M.K.
Publikováno v:
BMC Medicine, 13. BioMed Central Ltd.
BMC Medicine
BMC Medicine, 13, 156
BMC Medicine
BMC Medicine, 13, 156
Background Annexin A1 (ANXA1) is a protein related with the carcinogenesis process and metastasis formation in many tumors. However, little is known about the prognostic value of ANXA1 in breast cancer. The purpose of this study is to evaluate the as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63b9ee36942202ef3067b80b3e16662
https://hdl.handle.net/1887/51532
https://hdl.handle.net/1887/51532